Patient Guide: A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 35 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06298565
Status: 🟢 Enrolling Now
Condition: Myasthenia Gravis
Phase: Not Specified

Where You Can Participate

This study is available at 35 locations across the country.

Top locations include:
  • • San Francisco, California
  • • Boca Raton, Florida
  • • Jacksonville Beach, Florida
  • • And 32 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa - Join Clinical Trial NCTNCT06298565

How to Join This Clinical Trial - NCTNCT06298565

Learn how to participate in this Not Specified trial studying an investigational therapy for Myasthenia Gravis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myasthenia Gravis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myasthenia Gravis
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06298565 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 35 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94143 - United States

Status: RECRUITING

Clinical Research Site

Boca Raton, Florida 33487 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville Beach, Florida 32209 - United States

Status: RECRUITING

Clinical Research Site

Port Charlotte, Florida 33952 - United States

Status: RECRUITING

Clinical Research Site

St. Petersburg, Florida 33705 - United States

Status: RECRUITING

Clinical Research Site

O'Fallon, Illinois 62701 - United States

Status: RECRUITING

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40241 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: RECRUITING

And 25 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Myasthenia Gravis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships